STOP: Diagnostic Overclaiming From Discovery Phase Microbiome Data (Pancreatic Cancer)

<!— STUB: needs expansion —>

Overview

STOP: Diagnostic Overclaiming from Discovery-Phase Microbiome Data (Pancreatic Cancer)

References (4)

  1. Yixuan Meng, Feng Wu, Soyoung Kwak et al. (2025). Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer. JAMA Oncology. doi:10.1001/jamaoncol.2025.3377
  2. Neil Daniel, Riccardo Farinella, Anastasia Chrysovalantou Chatziioannou et al. (2024). Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study. Scientific Reports. doi:10.1038/s41598-024-77431-5
  3. Zhichen Jiang, Yiping Mou, Huiju Wang et al. (2023). Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study. BMC Cancer. doi:10.1186/s12885-023-11493-y
  4. Ailin Wei, Huiling Zhao, Xue Cong et al. (2022). Oral mycobiota and pancreatic ductal adenocarcinoma. BMC Cancer. doi:10.1186/s12885-022-10329-5